Vaccine Manufacturing

Vaccine Manufacturing

Custom vaccines from Cambridge Technologies are formulated and produced at our USDA-licensed 37,000-square-foot production facility, featuring a state-of-the-art fermentation suite. Our experienced team adapts commercial vaccine technologies to create USDA-approved bacterial and viral products. No matter the size of the order, Cambridge Technologies can meet your needs. Cambridge Technologies has the ability to customize products to each customer’s individual needs, including the potential for antigen concentration, multiple adjuvant choices, a range of label color options, and the option of SoliDose implants in bovine products.

Features and options of our Production facility include:

  • Batch size capacity of 1,500 liters
  • 600L and 1,600L fermenters for large-scale production
  • Dedicated areas for virus and bacterin production
  • ISO Class 5 fill suites
  • Production methods that optimize antigen expression
  • Flexibility in formulation: dose size, bottle size, preservative-free product, adjuvant-free concentrated antigen
  • Microfiltration and ultrafiltration techniques